文献速递肝病

全球肝硬化患者细菌感染的流行病学与影响

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
PubMed 文献 · Gastroenterology · 2018-12-13

该多中心前瞻性洲际研究纳入46个中心1302例住院肝硬化合并细菌或真菌感染患者,发现全球多重耐药(MDR)细菌感染患病率为34%(95%CI 31%-37%),亚洲最高,MDR感染与更低的感染消退率、更高的休克和新发器官衰竭发生率及更高的院内死亡率相关,充分的经验性抗生素治疗与改善院内和28天生存独立相关。

要点

  • 全球肝硬化住院患者MDR细菌感染患病率为34%(95%CI 31%-37%),亚洲地区最高。
  • MDR细菌感染的独立危险因素包括亚洲(尤其印度)感染、住院前3个月使用抗生素、既往医疗暴露和感染部位。
  • 充分的经验性抗生素治疗与改善院内和28天生存独立相关。

核心结论

  • 全球住院肝硬化患者中MDR细菌感染患病率高,不同地区患病率存在差异,提示不同大洲和国家需要不同的经验性抗生素策略。
  • 在等待新抗生素的同时,应努力减少MDR细菌在肝硬化患者中的传播。

研究设计与样本

  • 多中心前瞻性洲际研究,纳入46个中心(亚洲15个、欧洲15个、南美洲11个、北美洲5个)自2015年10月至2016年9月的1302例住院肝硬化合并细菌或真菌感染患者。
  • 收集感染诊断时和住院期间的人口学、临床、微生物学及治疗数据,随访至死亡、肝移植或出院。

主要发现

  • 全球MDR细菌患病率为34%(95%CI 31%-37%)。
  • MDR细菌患病率在不同地理区域间差异显著,亚洲患病率最高。
  • MDR细菌感染的独立危险因素为亚洲(尤其印度)感染、住院前3个月使用抗生素、既往医疗暴露和感染部位。
  • MDR细菌感染较非MDR细菌感染与更低的感染消退率、更高的休克和新发器官衰竭发生率及更高的院内死亡率相关。
  • 充分的经验性抗生素治疗与改善院内和28天生存独立相关。

临床怎么用

  • 不同全球区域的MDR细菌感染患病率差异提示不同大洲和国家需要不同的经验性抗生素策略。
  • 在等待新抗生素的同时,应努力减少MDR细菌在肝硬化患者中的传播。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Bacterial infections are common and life-threatening in patients with cirrhosis. Little is known about the epidemiology of bacterial infections in different regions. We performed a multicenter prospective intercontinental study to assess the prevalence and outcomes of bacterial and fungal infections in patients with cirrhosis. METHODS: We collected data from 1302 hospitalized patients with cirrhosis and bacterial or fungal infections at 46 centers (15 in Asia, 15 in Europe, 11 in South America, and 5 in North America) from October 2015 through September 2016. We obtained demographic, clinical, microbiology, and treatment data at time of diagnosis of infection and during hospitalization. Patients were followed until death, liver transplantation, or discharge. RESULTS: The global prevalence of multidrug-resistant (MDR) bacteria was 34% (95% confidence interval 31%-37%). The prevalence of MDR bacteria differed significantly among geographic areas, with the greatest prevalence in Asia. Independent risk factors for infection with MDR bacteria were infection in Asia (particularly in India), use of antibiotics in the 3 months before hospitalization, prior health care exposure, and site of infection. Infections caused by MDR bacteria were associated with a lower rate of resolution of infection, a higher incidence of shock and new organ failures, and higher in-hospital mortality than those caused by non-MDR bacteria. Administration of adequate empirical antibiotic treatment was independently associated with improved in-hospital and 28-day survival. CONCLUSIONS: In a worldwide study of hospitalized patients, we found a high prevalence of infection with MDR bacteria in patients with cirrhosis. Differences in the prevalence of MDR bacterial infections in different global regions indicate the need for different empirical antibiotic strategies in different continents and countries. While we await new antibiotics, effort should be made to decrease the spread of MDR bacteria in patients with cirrhosis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Piano S, Singh V, Caraceni P, et al. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. Gastroenterology. 2018. PMID: 30552895. doi:10.1053/j.gastro.2018.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。